compounded glp 1 going away GLP-1 - Semaglutide & Tirzepatide action GLP Discover Magazine | Scientists found
Description
The pharmaceutical industry is developing newer and potentially cheaper or more effective molecules that target GLP-1 and associated pathways (for example, the so-called dual- and triple-agonists tirzepatide, retatutride and orfoglipon) 257,258
sales of GLP-1 drugs were $13.7 billion

But big picture, biologically, humans evolved in scarcity

Stimple SD, Kalyoncu S, Desai AA, Mogensen JE, Spang LT, Asgreen DJ, et al

Many clinics make you wait days, so this stood out

The CDC cites that one in five children has obesity ( 4 )
